David G Acton

Title: David G Acton: Innovator in Cephalosporin Antibiotics

Introduction

David G Acton is a notable inventor based in Rudheath, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin antibiotics. With a total of 2 patents, his work has had a meaningful impact on antibiotic research and development.

Latest Patents

Acton's latest patents focus on intermediates for cephalosporin compounds. These patents describe cephalosporin antibiotics that feature a 3-position substituent with specific chemical formulas. The compounds include various substituents, where R.sup.1 can be hydrogen or certain substituted alkyl groups, and Z can be CH or N. Additionally, R.sup.2 and R.sup.3 are hydroxy or in vivo hydrolysable esters. The processes for their preparation and use are also detailed in his patents.

Career Highlights

David G Acton is associated with Imperial Chemical Industries Limited, a company known for its innovative contributions to the chemical industry. His work at this organization has allowed him to explore and develop new antibiotic compounds that are crucial in combating bacterial infections.

Collaborations

Throughout his career, Acton has collaborated with notable colleagues, including David Huw Davies and Jeffrey P Poyser. These collaborations have likely enhanced the research and development processes in which he has been involved.

Conclusion

David G Acton is a distinguished inventor whose work in cephalosporin antibiotics has contributed to advancements in medical science. His patents and collaborations reflect his commitment to innovation in the pharmaceutical industry.